Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04157179 · ClinicalTrials.gov registry record · NA

Cerebral Oxygen Metabolism in Children

A NA study of Sickle Cell Disease and Cerebral Stroke, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT04157179: Recruiting NA study of Sickle Cell Disease and Cerebral Stroke, sponsored by Washington University School of Medicine.

NCT04157179 is a NA study of Sickle Cell Disease and Cerebral Stroke that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 350 participants, above the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04157179, a NA study of Sickle Cell Disease and Cerebral Stroke, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. We will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or psychological stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In extreme circumstances, if the brain is unable to get enough oxygen for a long time, a stroke may occur. Sometimes small strokes occur without other noticeable changes and are only detectable on an MRI. These are sometimes called "silent strokes." In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should. One way to test the ability of blood vessels to expand is by measuring blood flow while breathing in carbon dioxide. Carbon dioxide causes blood vessels in the brain to dilate without increasing brain metabolism. During this study participants may be asked to undergo a blood draw, MRI, and potential neuropsychological assessments. It is also possible that the study team will use a special mask to control the amount of carbon dioxide the participants breathe in so they don't breathe in too much.

Interventions

  • OTHER Carbon Dioxide

Study Locations (1)

Missouri

  • Washington University of St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2019-10-17
Est. Completion 2027-12
Phase NA

What NCT04157179 shows while recruiting

NCT04157179 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (20% higher).

The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Carbon Dioxide is the first listed.

NCT04157179 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT04157179 about?

NCT04157179 is a clinical study titled "Cerebral Oxygen Metabolism in Children". The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. We will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to reg...

What is the current status of trial NCT04157179?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2019-10-17. Estimated completion is 2027-12.

What conditions does trial NCT04157179 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Cerebral Stroke.

What interventions are being tested in trial NCT04157179?

The interventions under investigation include: Carbon Dioxide (OTHER).

Who is sponsoring clinical trial NCT04157179?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04157179 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04157179's enrollment target sits among peer trials

350 16th of 213 higher than 197 of 213 other Sickle Cell Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04157179, the US trial registry maintained by the National Library of Medicine. NCT04157179 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.